Mihael H. Polymeropoulos
2018
In 2018, Mihael H. Polymeropoulos earned a total compensation of $4.3M as President and Chief Executive Officer at Vanda Pharmaceuticals, a 13% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $700,000 |
|---|---|
| Option Awards | $1,610,154 |
| Salary | $700,000 |
| Stock Awards | $1,237,200 |
| Other | $37,322 |
| Total | $4,284,676 |
Polymeropoulos received $1.6M in option awards, accounting for 38% of the total pay in 2018.
Polymeropoulos also received $700K in non-equity incentive plan, $700K in salary, $1.2M in stock awards and $37.3K in other compensation.
Rankings
In 2018, Mihael H. Polymeropoulos' compensation ranked 2,539th out of 14,244 executives tracked by ExecPay. In other words, Polymeropoulos earned more than 82.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,539 out of 14,244 | 82nd |
Division Manufacturing | 934 out of 5,765 | 84th |
Major group Chemicals And Allied Products | 319 out of 2,128 | 85th |
Industry group Drugs | 259 out of 1,817 | 86th |
Industry Pharmaceutical Preparations | 202 out of 1,391 | 86th |
Source: SEC filing on April 25, 2019.
Polymeropoulos' colleagues
We found four more compensation records of executives who worked with Mihael H. Polymeropoulos at Vanda Pharmaceuticals in 2018.
2018
Timothy Williams
Vanda Pharmaceuticals
General Counsel
2018
Gian Reverberi
Vanda Pharmaceuticals
Senior Vice President, Chief Commercial Officer
2018
James Kelly
Vanda Pharmaceuticals
Chief Financial Officer
2018
Gunther Birznieks
Vanda Pharmaceuticals